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Abstract
Research conducted during the last decades has provided increasing evidence for the use
of psychological treatments for a number of psychiatric disorders and somatic complaints.
However, by focusing only on the positive outcomes, less attention has been given to the
potential of negative effects. Despite indications of deterioration and other adverse and
unwanted events during treatment, little is known about their occurrence and characteris-
tics. Hence, in order to facilitate research of negative effects, a new instrument for monitor-
ing and reporting their incidence and impact was developed using a consensus among
researchers, self-reports by patients, and a literature review: the Negative Effects Question-
naire. Participants were recruited via a smartphone-delivered self-help treatment for social
anxiety disorder and through the media (N = 653). An exploratory factor analysis was per-
formed, resulting in a six-factor solution with 32 items, accounting for 57.64% of the vari-
ance. The derived factors were: symptoms, quality, dependency, stigma, hopelessness,
and failure. Items related to unpleasant memories, stress, and anxiety were experienced by
more than one-third of the participants. Further, increased or novel symptoms, as well as
lack of quality in the treatment and therapeutic relationship rendered the highest self-
reported negative impact. In addition, the findings were discussed in relation to prior
research and other similar instruments of adverse and unwanted events, giving credence to
the items that are included. The instrument is presently available in eleven different lan-
guages and can be freely downloaded and used from www.neqscale.com.
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Introduction
Psychological treatments have the potential of alleviating mental distress and enhancing well-
being for many patients suffering from psychiatric disorders and somatic complaints. Research
of such methods as cognitive behavior therapy (CBT) indicate that they are effective and can
have long-term benefits, both in research settings and in regular outpatient clinics [1–3].
Meanwhile, different ways of increasing access to psychological treatments have been explored,
both by introducing national guidelines and recommendations to health-care providers [4–6],
and by investigating the usefulness of Internet or smartphone delivered treatment interven-
tions [7–9]. However, although promising in relation to disseminating best available care, little
attention has thus far been given to the potential of negative effects of psychological treatments
[10]. Most clinical trials focus on the average treatment outcome and the number of patients
achieving clinical significant change, that is, attaining a positive result that fulfills a predeter-
mined diagnostic criterion or is beyond a statistical cutoff, while ignoring the fact that some
patients might also experience adverse or unwanted events [11–13]. In comparison to pharma-
cological research, studies involving psychological treatments seldom report the possibility of
negative effects [14]. A recent review showed that only one-fifth of a large number of random-
ized controlled trials mentioned the occurrence of harm [15]. The situation has more or less
remained the same throughout history, presumably because efforts were made to determine
the efficacy of psychological treatments and establish their position in relation to medicine
[16], thereby missing to examine the probability of negative effects during the treatment
period. Adverse and unwanted events were, however, mentioned in an evaluation in the 1950’s
regarding the Cambridge-Somerville Youth Study of delinquent adolescents, indicating that a
larger proportion of those assigned to the intervention group actually were to commit more
crimes than those allocated to the control group [17]. Likewise, Bergin [18] was able to provide
evidence of patients deteriorating in seven different outcome studies, arguing that between five
to ten percent consistently seem to deteriorate. Although obtaining critique for the difficulty of
determining a causal relationship [19], that is, proving that the treatment interventions and
not any other circumstances are responsible for the patients faring worse, the numbers have
been confirmed in later reviews and across various treatment modalities and psychiatric disor-
ders [20–22], suggesting that deterioration is to be expected and controlled for to reverse a neg-
ative treatment trend [23].
Deterioration is, however, far from the only negative effect that might occur during psycho-
logical treatments. Hadley and Strupp [24] were early to recognize a wide range of adverse and
unwanted events, for instance, social stigma, dependency, and novel symptoms. Similarly,
Mays and Franks [25], introducing the term negative outcome, argued that any type of signifi-
cant decline in one or more areas of functioning during the treatment period should be
regarded as negative, not just deterioration in symptomatology. Others have also implied that
nonresponse, dropout, and interpersonal difficulties may be perceived as negative effects [26–
28], although the prospect of establishing a cause-effect relationship is complex owing to the
influence of other factors, most notably, the natural fluctuations in psychiatric disorders, the
undesirable impact of everyday stressors, as well as what perspective is being used to judge
whether or not a negative effect has occurred. Strupp and Hadley [29], for example, presented
a tripartite model for assessing the positive as well as negative effects of psychological treat-
ments, suggesting that the outcome will depend on the eye of the beholder: the patient, the
therapist, or society at large. A specific response occurring during the treatment period, for
instance, increased anxiety in an exposure exercise, might be perceived as negative by the
patient, but can be expected and perhaps even regarded as beneficial by the therapist providing
the treatment. Thus, even though there are reasons to assume that other types of negative
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effects exist in psychological treatments, determining their occurrence is complicated and war-
rants both theoretical and methodological considerations.
Different suggestions on how to monitor and report negative effects have, nonetheless, been
put forward, and the need for more research has been emphasized [30–32]. Deterioration has,
for instance, long been regarded as a relatively straightforward method for assessing the num-
ber of patients faring worse on a given outcome measure [33]. In addition, both therapist and
patient administered measures have been proposed. One early attempt was the Vanderbilt
Negative Indicators Scale (VNIS), a comprehensive therapist rating system to determine the
occurrence of various negative effects using tape-recorded sessions [34]. The VNIS distin-
guished between 42 different items on five different subscales (scored 0–5), e.g., unrealistic
expectations (patient personal qualities), deficiencies in therapeutic commitment (therapist
personal qualities), inflexible use of therapeutic techniques (errors in technique), poor thera-
peutic relationship (patient-therapist interaction), and poor match (global session ratings).
Albeit highly ambitious and theory driven [35], the initial evaluation only consisted of two
samples of 10 and 18 patients, and the internal consistencies and interrater reliability revealed
great irregularity [36]. As for their relationship with treatment outcome, errors in technique
showed the strongest association, although the results seemed to vary between treatment
modalities and few correlations remained significant after partialling out the effect of the other
subscales. Also, with the exception for a limited number of psychodynamic psychotherapy
studies [37, 38], the VNIS never became popular by researchers or therapists. Other instru-
ments have been proposed since then, such as, the Experiences of Therapy Questionnaire
(ETQ) [39]. A principal component analysis was used on data from 716 patients undergoing or
having prior experiences of being in psychological treatment, revealing a rotated solution of
five components explaining 53.4% of the variance. Of the original 103 items that were gener-
ated, 63 were retained (scored 1–5), e.g., “My therapist doesn’t seem to understand what I want
to get out of therapy” (Item 11). The components included such areas as negative therapist
(e.g., lack of empathy), pre-occupying therapy (e.g., feeling alienated), beneficial therapy (e.g.,
increased insight), idealization of therapist (e.g., feeling dependent on the therapist), and pas-
sive therapist (e.g., inexperienced therapist) [40]. The components were subsequently related
to different sociodemographic variables, type of psychological treatment, frequency of sessions,
and reasons for entering and discontinuing therapy, indicating that younger patients termi-
nated early on because the therapist was too passive or unable to solve any problems, and that
many patients believed their therapy was ineffective. Albeit using a large and heterogeneous
sample in terms of psychiatric disorders and treatment modalities, the generation of items was
not entirely clear and included both negative and positive effects, rather than providing an
instrument that solely investigates adverse or unwanted events. Furthermore, all comparisons
were made post hoc and not according to any initial hypotheses, increasing the risk of obtain-
ing spurious findings. Linden [41], on the other hand, presented a different approach to exam-
ining negative effects, the Unwanted to Adverse Treatment Reaction (UE-ATR) checklist, a
therapist-administered instrument for assessing a wide range of potential adverse and
unwanted effects, for instance, lack of clear treatment results, prolongation of treatment, and
non-compliance of the patient. The therapist is also supposed to determine how the negative
effects were linked to the psychological treatment using a five-step scale ranging from unrelated
to related, and an evaluation of their severity level, e.g., mild, moderate, and severe. Conceptu-
ally, the UE-ATR resembles the VNIS in that the negative effects can involve different areas of
life, not only deterioration of symptomatology, and that the relationship with treatment is not
always clear. However, as stated by Linden and Schermuly-Haupt [30], the instrument is more
of a tool for improving the therapist’s ability to detect negative effects than a scale with distin-
guishable psychometric properties, although it has been used in at least one clinical trial [42].
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As for other instruments, the Inventory for the Assessment of Negative Effects of Psychother-
apy (INEP) has also been put forward [43]. After performing a literature review and consulting
psychotherapy researchers, 120 items were generated (scored on a three-step scale regarding
change or a four-step scale in terms of agreement), such as, “I feel addicted to my therapist”
(Item 10). Of these, 52 items were selected and distributed to 195 patients that had undergone
psychological treatment and who were recruited via advertisements. Using a principal compo-
nent analysis and a confirmatory factor analysis, the results yielded a rotated solution of five or
seven components/factors, depending on the type of analysis; intrapersonal changes, intimate
relationship, stigmatization, emotions, workplace, therapeutic malpractice, and family and
friends, accounting for 46.7 or 55.8% of the variance (the final version consists of 21 items).
Interestingly, the results indicated that more patients in behavioral than psychodynamic or
nondirective therapy felt forced by their therapist to implement certain interventions, while
patients in nondirective therapy had longer periods of depression after the treatment period,
and patients in psychodynamic therapy more frequently felt offended by their therapist.
Although carefully developed and providing some useful recommendations, most notably, ask-
ing the patient to differentiate between negative effects of their treatment and other circum-
stances, the INEP is difficult to score and assess in relation to treatment outcome as it does not
include a clear and coherent scale. Further, several items could be criticized on theoretical
grounds, for instance, “I have trouble finding insurance or am anxious to apply for new insur-
ances” (Item 8), as it might not always be applicable in different contexts. Also, a large number
of items seem to convey malpractice issues, such as, “My therapist attacked me physically”
(Item 19), and not negative effects of properly performed psychological treatments. Although
they most certainly will have a negative impact, it could be argued that malpractice issues are
related to the unethical behavior of a therapist rather than a feature of the treatment interven-
tions [11].
Hence, in order to address some of the shortcomings that have been mentioned, a new
instrument for assessing negative effects of psychological treatments was developed: the Nega-
tive Effects Questionnaire (NEQ). Items were generated by consulting a number or researchers
[32], distributing open-ended questions [42], analyzing patient responses using qualitative
method [44], and a comprehensive literature review. The purpose of this process was to present
an instrument that is based on both theoretical considerations and empirical findings, with
items being systematically derived, reasonable to expect, and comprehensible for the patient.
The overall purpose of the current study is to determine the validity and factor structure of the
instrument, and to examine what items should be retained in a final version. This is believed to
result in an instrument that is accessible and easier to administer by researchers and therapists,
which might aid the investigation of negative effects in a variety of different psychological treat-
ments and to explore their relationship with treatment outcome. Providing an instrument that
can identify adverse and unwanted events during the treatment period may also help therapists
identify patients at risk of faring worse, and to offer other treatment interventions as a way of
reversing a negative treatment trend.
Methods
Item design
Items were carefully generated using a consensus statement regarding the monitoring and
reporting of negative effects [32], findings from a treatment outcome study of patients with
social anxiety disorder that probed for adverse and unwanted events [42], the results of a quali-
tative content analysis of the responses from four different clinical trials [44], and a literature
review of books and published articles on negative effects. This is in line with the
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recommendations by Cronbach and Meehl [45], advising researchers to articulate the theoreti-
cal concept of an instrument before developing and testing it empirically in order to increase
content validity. Also, instead of restricting the number of items to be included in a final ver-
sion, the concept of overinclusiveness was adapted, that is, embracing more items than neces-
sary to aid the statistical analyses necessary for detecting those that are related to the
underlying construct(s) [46]. Subsequently, 60 items were generated, characterized by interper-
sonal issues, problems with therapeutic relationship, deterioration, novel symptoms, stigma,
dependency, hopelessness, difficulties understanding the treatment content, as well as prob-
lems implementing the treatment interventions. An additional open-ended question was also
included for the investigation of negative effects that might have been experienced but were
not listed, i.e., “Describe in your own words whether there were any other negative incidents or
effects, and what characterized them”. Further, in order to assess the readability and under-
standing of the items, cognitive interviews were conducted on five individuals unrelated to the
current study and without any prior knowledge of negative effects or psychological treatments,
i.e., encouraging them to read the items out load and speak freely of whatever comes to mind
[47]. Cognitive interviews are often suggested as a way of pretesting an instrument so that irrel-
evant or difficult items can be revised and to increase its validity [48]. In relation to the pro-
posed items, several minor changes were made, e.g., rephrasing or clarifying certain
expressions. In addition, the instrument included general information about the possibility of
experiencing negative effects, and was comprised of three separate parts; 1) “Did you experi-
ence this?” (yes/no) 2) “If yes–here is how negatively it affected me” (not at all, slightly, moder-
ately, very, and extremely), and 3) “Probably caused by” (the treatment I received/other
circumstances). The instrument is scored 0–4 and contains no reversed items as this may intro-
duce errors or artifacts in the responses [49].
Data collection
The instrument was distributed via the Internet using an interface for administering surveys
and self-report measures, Limesurvey (www.limesurvey.org). Participants were recruited via
two different means in order to include a diverse and heterogeneous sample: patients undergo-
ing a smartphone-delivered self-help treatment for social anxiety disorder based on CBT
(N = 189) [50], and individuals responding to an article on negative effects of psychological
treatments featured in the largest morning newspaper in Sweden as well as a Swedish public
radio show on science with the same topic, (N = 464), yielding a total sample size of 653. As for
the treatment group, patients were instructed to complete the instrument on negative effects
while responding to the outcome measures at the post treatment assessment, resulting in a
response rate of 90.4%. In terms of the media group, information on negative effects and the
purpose of the current study was presented on a website specifically created for the purpose of
the current study (www.psykoterapiforskning.se), where the individuals were instructed to fill
out the instrument and information on sociodemographics, rendering a response rate of 49.4%
(defined as those who entered the website and completed the instrument). Inclusion criteria
for the treatment group, that is, to be included in the clinical trial, were; above 30 points on the
Liebowitz Social Anxiety Scale–Self-Report [51], social anxiety disorder according to The
Mini-International Neuropsychiatric Interview (MINI) [52], access to an IPhone, at least 18
years of age, and being a Swedish resident. Suicidality, ongoing psychological treatment, or a
recent commencement or alteration of any psychotropic medication were all reasons for exclu-
sion from the clinical trial. With regard to the media group, inclusion criteria comprised only
of having undergone or being in psychological treatment sometime during the last two years.
None of the two groups received any monetary compensation to complete the instrument.
The Negative Effects Questionnaire
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Statistical analysis
All data was assembled and organized in one main dataset, and the statistical analyses were
performed on IBM SPSS Statistics, version 22. As the purpose of the current study was to pres-
ent an instrument for assessing negative effects of psychological treatments, only items that
were attributable to treatment by the participants were analyzed. In order to determine the
validity and factor structure of the instrument, an exploratory factor analysis (EFA) was con-
ducted using principal axis factoring. This method is suitable for assessing theoretically inter-
esting latent constructs rather than to test a specific hypothesis [53], corresponding to the
purpose of the current study. Also, for an EFA to be appropriate, the level of measurement
must be considered to be interval, or, at least quasi-interval, which could be assumed for the
data that were collected [54]. In comparison to other methods for investigating the underlying
dimensions of an instrument, such as, principal component analysis, an EFA also accounts for
measurement error, argued to result in more realistic assumptions [55]. As for the rotated solu-
tion used for extracting the number of factors, an oblique rotation was implemented using
direct oblimin with delta set to zero and the number of iterations set to 40. As discussed by
Browne [56], an oblique rotation permits factors to be correlated, which orthogonal rotation
does not, and is thus more representative of social science data where it is reasonable to assume
that different factors in the same instrument will in fact correlate to some degree. Additional
analyses implemented for considering the appropriateness of EFA were the Kaiser-Meyer-
Olkin (KMO) measure of sampling adequacy, assessing the potential for finding distinct and
reliable factors, the Bartlett’s Test of Sphericity, which indicates if the correlations between
items are significantly different from zero, as well as the Determinant, checking for a reason-
able level of correlations. In addition, item-item correlations< .30 or>.90 were considered to
see if items measure the same underlying construct and to investigate the risk of multicollinear-
ity. In order to establish the validity of the extracted factor solution, several methods were used.
Eigenvalues greater than one, the Kaiser criterion, was only utilized as a preliminary analysis,
given that it has been found to result in both over- and underfactoring [57]. The scree test was
then implemented to visually inspect the number of factors that precedes the last major drop in
eigenvalues [58], although it needs to be validated by other means as it is deemed a highly sub-
jective procedure [59]. Hence, parallel analysis was performed, i.e., comparing the obtained fac-
tor solution with one derived from data that is produced at random with the same number of
cases and variables, meaning that the correct number of factors should equal to eigenvalues
higher than those that are randomly generated [60]. As SPSS does not perform parallel analysis,
syntax from O’Connor [61] was used. Moreover, to examine the validity of the factor solution
across samples, a stability analysis was conducted by making SPSS select half of the cases at
random and then retesting the factor solution [53], with similar results indicating if its rela-
tively stable. The interpretability of the factors was also checked to see if it was reasonable and
fits well with prior theoretical assumptions and empirical findings [62].
Ethical considerations
All data included in the current study were manually imputed by the participants and assigned
an auto generated identification code, i.e., 1234abcd, allowing complete anonymity. As for the
treatment group, ethical approval was obtained by the Regional Ethical Board in Stockhom,
Sweden (Dnr: 2014/680-31/3), and written informed consent was collected by letter at the pre
treatment assessment. The consent form included information regarding the clinical trial, how
to contact the principal investigator, data management and confidentiality, and the right to
obtain a copy of one’s personal record in accordance with the Swedish Personal Data Act. With
regard to the media group, information about the authors as well as the current study was
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provided, and a written informed consent with the same details as above was submitted digi-
tally before responding to the instrument. Moreover, the results are only presented on group
level, and great consideration was made in order not to disclose the identity of a specific
participant.
Results
Participants
A total sample of 653 participants was included in the current study, with a majority being
women (76.6%), in their late thirties, and in a relationship (60%). A large proportion had at
least a university degree (62%) and were either employed (52.7%) or students (25.1%). In terms
of the reason for receiving psychological treatment according to the participants themselves,
anxiety disorders were most prevalent (48.4%), compared to mixed anxiety/depression
(14.1%), depression (10.1%), and other psychiatric disorders or psychological problems
(27.4%). As for the therapeutic orientation the participants believed they had received, cogni-
tive/behavioral was predominant (61.3%), which includes several different modalities, e.g.,
schema therapy, cognitive therapy, as well as acceptance and commitment therapy, followed by
psychodynamic psychotherapy (17.2%). Prior or ongoing psychotropic medication was also
relatively common (38.3%). See Table 1 for an overview of the participants, divided by means
of recruitment.
Principal axis factoring
The preliminary assessment revealed a KMO of .94 and that the Bartlett’s Test of Sphericity
was significant. Also, the Determinant indicated a reasonable level of correlations, suggesting
that the data was suitable for performing an EFA. None of the off-diagonal items had correla-
tions of>.90, suggesting no risk of multicollinearity. However, fourteen items had a large num-
ber of correlations of< .30 and were therefore subject for further investigation. Furthermore,
four items specifically related to Internet-based psychological treatments, e.g., “I wasn’t satis-
fied by the user interface in which the treatment was being delivered” (Item 58), only consisted
of correlations below the threshold and were deemed susceptible for removal. The communal-
ity estimates of the extracted factor solution, which reflects each item’s variance explained by
all of the factors in the model, resulted in an average of .52, recommending the use of the scree
test as an aid to the Kaiser criterion to determine the number of factors to retain. In terms of
the former, a three-factor solution seemed reasonable, but using the latter, five factors had an
eigenvalue greater than one, with an additional two factors being>.90, explaining a variance of
45.50%. Albeit resulting in two factor solutions, retaining seven factors was regarded most
appropriate and was used for further examination.
A closer inspection of the extracted factor solution indicated that two items could be
removed as the correlations were too small or because they would enhance the internal consis-
tency if replaced. Moreover, the seventh factor was only comprised of items that conveyed neg-
ative effects of Internet-based psychological treatments, which previously had been found to be
unrelated to the underlying construct(s). Therefore, a six factor solution seemed more sensible
to maintain, whereby an EFA was performed using only six factors and with the problematic
items having been removed. The results indicated that four factors were above the Kaiser crite-
rion, one was>.90, and one resulted in an eigenvalue of .68, accounting for 57.64% of the vari-
ance. Although the last factor was well below the threshold, it was considered appropriate for
retention due to theoretical reasons, that is, reflecting the experience of failure during psycho-
logical treatment. For a full overview of the specific items, the six-factor solution, and the corre-
lations between each item and their respective factor can be found in Table 2.
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In order to validate the six-factor solution, a parallel analysis was performed using a permu-
tation test of 1000 iterations with the same number of cases and variables as the original data-
set. That is, similar to bootstrapping procedures, a total of 1000 random datasets were
produced, and an average eigenvalue and 95% Confidence Interval (CI) was reported for each
factor. Both according to the scree test and a comparison between the eigenvalues obtained in
the six-factor solution and the parallel analysis indicated that the original factor solution was
Table 1. Sociodemographic characteristics of participants divided by means of recruitment.
Treatment group (n = 189) Media group (n = 464) Total sample (n = 653)
Gender: n (% female) 146 (77.2) 354 (76.3) 500 (76.6)
Age (years): M (SD) 35.3 (12.5) 38.0 (12.3) 37.2 (12.4)
Civil status: n (%)
Single 64 (33.9) 194 (41.8) 258 (39.5)
Relationship 122 (64.6) 270 (58.2) 392 (60)
Other 3 (1.6) n.a. c 3 (0.5)
Children: n (% yes) 95 (50.3) n.a. c 95 (14.5)
Cohabitant: n (% yes) 134 (70.9) n.a. c 134 (20.5)
Highest educational level: n (%)
Elementary school 10 (5.3) 18 (3.9) 28 (4.3)
High school/college 73 (38.6) 147 (31.7) 220 (33.7)
University 104 (55.0) 287 (61.9) 391 (59.9)
Postgraduate 2 (1.1) 12 (2.6) 14 (2.1)
Employment: n (%)
Unemployed 14 (7.4) 28 (6.0) 42 (6.4)
Student 45 (23.8) 119 (25.6) 164 (25.1)
Employed 119 (63.0) 225 (48.5) 344 (52.7)
Parental leave 4 (2.1) 11 (2.4) 15 (2.3)
Retired 4 (2.1) 22 (4.7) 26 (4.0)
Sick-leave 3 (1.6) 59 (12.7) 62 (9.5)
Primary diagnosis: n (%)
Anxiety disorder 189 (100) 127 (27.4) 316 (48.4)
Anxiety and depression n.a. a 92 (19.8) 92 (14.1)
Depression n.a. a 66 (14.2) 66 (10.1)
Other n.a. a 179 (38.6) 179 (27.4)
Therapeutic orientation
Cognitive/behavioral 189 (100) 211 (45.5) 400 (61.3)
Psychodynamic n.a. b 112 (24.0) 112 (17.2)
Integrative n.a. b 30 (6.5) 30 (4.6)
Unclear n.a. b 82 (17.7) 82 (12.5)
Other n.a. b 29 (6.3) 29 (4.4)
Prior psychological treatment n (%
yes)
79 (41.8) n.a. d 79 (12.1)
Prior or ongoing psychotropic
medication n (% yes)
54 (28.6) 196 (42.2) 250 (38.3)
n.a. = not applicable
a Not applicable as diagnosis
b Not applicable as treatment orientation
c Not applicable as response alternatives
d Not applicable as prior or ongoing psychological treatment was an inclusion criterion
doi:10.1371/journal.pone.0157503.t001
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Table 2. Principal axis factoring for a six factor solution using oblique rotation.
Item Factor 1:
Symptoms
Factor 2: Quality Factor 3:
Dependency
Factor 4: Stigma Factor 5:
Hopelessness
Factor 6: Failure
1. I had more
problems with my
sleep
.572
2. I felt like I was
under more stress
.534
3. I experienced
more anxiety
.700
4. I felt more
worried
.554
5. I felt more
dejected
.625
6. I experienced
more hopelessness
.373
7. I experienced
lower self-esteem
.677
8. I lost faith in
myself
.708
9. I felt sadder .616
10. I felt less
competent
.555
11. I experienced
more unpleasant
feelings
.703
12. I felt that the
issue I was looking
for help with got
worse
.431
13. Unpleasant
memories
resurfaced
.692
14. I became afraid
that other people
would ﬁnd out about
my treatment
.738
15. I got thoughts
that it would be
better if I did not
exist anymore and
that I should take
my own life
.487
16. I started feeling
ashamed in front of
other people
because I was
having treatment
.771
17. I stopped
thinking that things
could get better
-.798
18. I started
thinking that the
issue I was seeking
help for could not
be made any better
-.719
(Continued)
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reasonable to retain. Hence, none of the six factors were below the mean eigenvalues or 95% CI
of the random of the randomly generated datasets. For a visual inspection please refer to Fig 1.
Further, as a measure of validity across samples, a stability analysis was conducted by mak-
ing SPSS randomly select half of the cases and retesting the factor solution. The results indi-
cated that the same six-factor solution could be retained, albeit with slightly different
eigenvalues, implying stability. A review of the stability analysis can be obtained in Table 3.
Table 2. (Continued)
Item Factor 1:
Symptoms
Factor 2: Quality Factor 3:
Dependency
Factor 4: Stigma Factor 5:
Hopelessness
Factor 6: Failure
19. I stopped
thinking help was
possible
-.626
20. I think that I
have developed a
dependency on my
treatment
.820
21. I think that I
have developed a
dependency on my
therapist
.819
22. I did not always
understand my
treatment
-.516
23. I did not always
understand my
therapist
-.634
24. I did not have
conﬁdence in my
treatment
-.849
25. I did not have
conﬁdence in my
therapist
-.844
26. I felt that the
treatment did not
produce any results
-.605
27. I felt that my
expectations for the
treatment were not
fulﬁlled
-.640
28. I felt that my
expectations for the
therapist were not
fulﬁlled
-.784
29. I felt that the
quality of the
treatment was poor
-.793
30. I felt that the
treatment did not
suit me
-.649
31. I felt that I did
not form a closer
relationship with my
therapist
-.592
32. I felt that the
treatment was not
motivating
-.615
doi:10.1371/journal.pone.0157503.t002
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Factor solution
The final factor solution consisted of six factors, which included 32 items. A closer inspection
of the results revealed one factor related to “symptoms”, e.g., “I felt more worried” (Item 4),
with ten items reflecting different types of symptomatology, e.g., stress and anxiety. Another
factor was linked to “quality”, e.g., “I did not always understand my treatment” (Item 23), with
eleven items characterized by deficiencies in the psychological treatment, e.g., difficulty under-
standing the treatment content. A third factor was associated with “dependency”, e.g., “I think
that I have developed a dependency on my treatment” (Item 20), with two items indicative of
becoming overly reliant on the treatment or therapist. A fourth factor was related to “stigma”,
e.g., “I became afraid that other people would find out about my treatment” (Item 14), with
two items reflecting the fear of being perceived negatively by others because of undergoing
treatment. A fifth factor was characterized by “hopelessness”, e.g., “I started thinking that the
issue I was seeking help for could not be made any better” (Item 18), with four items distin-
guished by a lack of hope. Lastly, a sixth factor was linked to “failure”, e.g., “I lost faith in
myself” (Item 8), with three items connected to feelings of incompetence and lowered self-
esteem.
Fig 1. Parallel analysis of the factor solution.
doi:10.1371/journal.pone.0157503.g001
Table 3. Stability analysis of the six-factor solution using a randomly selected sample.
Original sample (N = 653) Random sample (N = 326)
Eigen value Variance % Cumulative % Eigen value Variance % Cumulative %
1 Symptoms 11.71 36.58 36.58 12.45 38.91 38.91
2 Quality 2.79 8.71 45.29 2.85 8.90 47.81
3 Dependency 1.32 4.13 49.42 1.50 4.68 52.49
4 Stigma 1.01 3.16 52.59 1.10 3.43 55.92
5 Hopelessness 0.94 2.94 55.53 0.93 2.89 58.81
6 Failure 0.68 2.11 57.64 0.59 1.84 60.65
doi:10.1371/journal.pone.0157503.t003
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Table 4 contains the means, standard deviations, internal consistencies, and correlations
among the factors. With regard to the full instrument, α was .95, while it ranged from .72-.93
for the specific factors: lowest for stigma, and highest for quality. The largest correlations were
obtained between quality and hopelessness, r = .55, symptoms and failure, r = .50, and hope-
lessness and failure, r = -.49.
In terms of the items that were most frequently endorsed as occurring during treatment,
participants experienced; “Unpleasant memories resurfaced” (Item 13), 38.4%, “I felt like I was
under more stress” (Item 2), 37.7%, and “I experienced more anxiety” (Item 3), 37.2%. Like-
wise, the items that had the highest self-rated negative impact were; “I felt that the quality of
the treatment was poor” (Item 29), 2.81 (SD = 1.10), “I felt that the issue I was looking for help
with got worse” (Item 12), 2.68 (SD = 1.44), and “Unpleasant memories resurfaced” (Item 13),
2.62 (SD = 1.19). A full review of the items can be obtained in Table 5.
Discussion
The current study evaluated a new instrument for assessing different types of negative effects
of psychological treatments; the NEQ. Items were generated using consensus among research-
ers, experiences by patients having undergone treatment, and a literature review. The instru-
ment was subsequently administered to patients having received a smartphone-delivered self-
help treatment for social anxiety disorder and individuals recruited via two media outlets, hav-
ing received or were currently receiving treatment. An investigation using EFA revealed a six-
factor solution with 32 items, defined as: symptoms, quality, dependency, stigma, hopelessness,
and failure. Both a parallel analysis and a stability analysis suggested that the obtained factor
solution could be valid and stable across samples, with an excellent internal consistency for the
full instrument and acceptable to excellent α for the specific factors. The results are in line with
prior theoretical assumptions and empirical findings, giving some credibility to the factors that
were retained. Symptoms, that is, deterioration and distress unrelated to the condition for
which the patient has sought help, have frequently been discussed in the literature of negative
effects [24, 26, 30]. Research suggests that 5–10% of all patients fare worse during the treatment
period, indicating that deterioration is not particularly uncommon [63]. Furthermore, evidence
from a clinical trial of obsessive-compulsive disorder indicates that 29% of the patients experi-
enced novel symptoms [64], suggesting that other types of adverse and unwanted events may
occur. Anxiety, worry, and suicidality are also included in some of the items of the INEP [43],
implying that various symptoms are to be expected in different treatment settings. However,
these types of negative effects might not be enduring, and, in the case of increased symptom-
atology during certain interventions, perhaps even expected. Nonetheless, given their occur-
rence, the results from the current study recommends the monitoring of symptoms by using
Table 4. Means, standard deviations, internal consistencies, and correlates among the obtained factors.
Factor
M SD α 1 2 3 4 5 6
1 Symptoms 21.43 14.63 .90 -.40 .26 .28 -.45 .50
2 Quality 30.82 5.83 .93 -.40 -.09 -.18 .55 -.40
3 Dependency 4.21 2.74 .82 .26 -.09 .18 -.12 .16
4 Stigma 3.47 7.16 .72 .28 -.18 .18 -.20 .19
5 Hopelessness 7.19 3.84 .87 -.45 .55 -.12 -.20 -.49
6 Failure 6.84 4.34 .84 .50 -.40 .16 .19 -.49
Full
instrument
20.38 26.10 .95
doi:10.1371/journal.pone.0157503.t004
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Table 5. Items, number of responses, mean level of negative impact, and standard deviations.
Item Responses n (%) M SD
1. I had more problems
with my sleep
135 (20.7) 1.70 1.72
2. I felt like I was under
more stress
246 (37.7) 1.84 1.62
3. I experienced more
anxiety
243 (37.2) 2.09 1.54
4. I felt more worried 191 (29.2) 2.04 1.58
5. I felt more dejected 194 (29.7) 1.88 1.61
6. I experienced more
hopelessness
140 (21.4) 2.15 1.55
7. I experienced lower
self-esteem
120 (18.4) 2.18 1.51
8. I lost faith in myself 115 (17.6) 2.11 1.58
9. I felt sadder 229 (35.1) 1.99 1.46
10. I felt less competent 117 (17.9) 2.16 1.44
11. I experienced more
unpleasant feelings
199 (30.5) 2.35 1.38
12. I felt that the issue I
was looking for help with
got worse
112 (17.2) 2.68 1.44
13. Unpleasant
memories resurfaced
251 (38.4) 2.62 1.19
14. I became afraid that
other people would ﬁnd
out about my treatment
88 (13.5) 1.63 1.38
15. I got thoughts that it
would be better if I did
not exist anymore and
that I should take my
own life
97 (14.9) 1.11 1.55
16. I started feeling
ashamed in front of other
people because I was
having treatment
57 (8.7) 1.65 1.58
17. I stopped thinking
that things could get
better
126 (19.3) 2.21 1.52
18. I started thinking that
the issue I was seeking
help for could not be
made any better
165 (25.3) 2.21 1.55
19. I stopped thinking
help was possible
122 (18.7) 2.25 1.62
20. I think that I have
developed a
dependency on my
treatment
74 (11.3) 2.05 1.26
21. I think that I have
developed a
dependency on my
therapist
68 (10.4) 2.03 1.37
22. I did not always
understand my treatment
207 (31.7) 2.24 1.09
23. I did not always
understand my therapist
166 (25.4) 2.19 1.25
(Continued)
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the NEQ in case they affect the patient’s motivation and adherence. Likewise, the perceived
quality of the treatment and relationship with the therapist are reasonable to influence well-
being and the patient’s motivation to change, meaning that a lack of confidence in either one
may have a negative impact. This is evidenced by the large correlation between quality and
hopelessness, suggesting that it could perhaps affect the patient’s hope of attaining some
improvement. Research has revealed that expectations, specific techniques, and common fac-
tors, e.g., patient and therapist variables, may influence treatment outcome [65]. In addition,
several studies on therapist effects have revealed that some could potentially be harmful for the
patient, inducing more deterioration in comparison to their colleagues [66], and interpersonal
issues in treatment have been found to be detrimental for some patients [67]. Similarly, diffi-
culties understanding the treatment or purpose of specific interventions could be regarded as
negative by the patient, presumably affecting both expectations and self-esteem. Items reflect-
ing deficiencies and lack of credibility of the treatment and therapist are also included in both
the ETQ and INEP [39, 43], making it sensible to expect negative effects due to lack of quality.
With regard to dependency, the empirical findings are less clear. Patients becoming overly reli-
ant on their treatment or therapist have frequently been mentioned as a possible adverse and
unwanted event [13, 24, 41], but the evidence has been missing. In reviewing the results from
questionnaires, focus groups, and written complaints, a recent study indicated that 17.9% of
the surveyed patients felt more dependent and isolated by undergoing treatment [68]. Both the
ETQ and INEP also contain items that are related to becoming addicted to treatment or the
therapist [39, 43]. Hence, it could be argued that dependency may occur and is problematic if it
Table 5. (Continued)
Item Responses n (%) M SD
24. I did not have
conﬁdence in my
treatment
129 (19.8) 2.43 1.21
25. I did not have
conﬁdence in my
therapist
114 (17.5) 2.50 1.22
26. I felt that the
treatment did not
produce any results
169 (25.4) 2.58 1.43
27. I felt that my
expectations for the
treatment were not
fulﬁlled
219 (33.5) 2.36 1.37
28. I felt that my
expectations for the
therapist were not
fulﬁlled
138 (21.1) 2.60 1.22
29. I felt that the quality
of the treatment was
poor
113 (17.3) 2.81 1.10
30. I felt that the
treatment did not suit me
159 (24.4) 2.49 1.33
31. I felt that I did not
form a closer
relationship with my
therapist
182 (27.9) 1.95 1.43
32. I felt that the
treatment was not
motivating
111 (17.0) 2.59 1.18
doi:10.1371/journal.pone.0157503.t005
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prevents the patient from becoming more self-reliant. However, the idea of dependency as
being detrimental is controversial given that it is contingent on both perspective and theoretical
standpoint. Dependency may be regarded as negative by significant others, but not necessarily
by the patient [29]. Also, dependency could be seen as beneficial with regard to establishing a
therapeutic relationship, but adverse and unwanted if it hinders the patient from ending treat-
ment and becoming an active agent [69]. Determining the issue of dependency directly, as in
using the NEQ, could shed some more light on this matter and warrants further research. In
terms of stigma, little is currently known about its occurrence, characteristics, and potential
impact. Linden and Schermuly-Haupt [30] discuss it as a possible area for assessing negative
effects. Being afraid that others might find out about one’s treatment is also mentioned in the
INEP [43]. Given the fact that much have been written about stigma and its interference with
mental health care [70–72], there is reason to assume that the idea of being negatively perceived
by others for having a psychiatric disorder or seeking help could become a problem in treat-
ment. However, whether stigma should be perceived as a negative effect attributable to treat-
ment or other circumstances, e.g., social or cultural context, remains to be seen. As for
hopelessness, the relationship is much clearer. Lack of improvement and not believing that
things can get better are assumed to be particularly harmful in treatment [28], and could be
associated with increased hopelessness [73]. Hopelessness is, in turn, connected to several neg-
ative outcomes, most notably, depression and suicidality [74], thus being of great importance
to examine during treatment. Hopelessness is included in instruments of depression, e.g., the
Beck Depression Inventory [75], “I feel the future is hopeless and that things cannot improve”
(Item 2), and is vaguely touched upon in the ETQ [39], i.e., referring to non-improvement.
Assessing it more directly by using the NEQ should therefore be of great value, particularly
given its relationship with more severe adverse events. Lastly, failure has been found to be
linked to increased stress and decreased well-being [76], especially if accompanied by an exter-
nal as opposed to internal attributional style [77], making it difficult to adequately cope with
setbacks [78]. Experiencing difficulties during treatment, as well as not improving, could be
presumed to be negative for the patient, resulting in lower self-esteem and competency. Corre-
lations between the factors give some support for this idea, as both symptoms and hopelessness
revealed moderate to large associations with failure. The ETQ mentions failure in one of its
items [39], but only in terms of the therapist making the patient feel incompetent. Feelings of
failure could be particularly damaging if it leads to drop out and prevents the patient from
seeking treatment in the future, suggesting that the NEQ might be useful for monitoring this
issue more closely.
As to the items that were most frequently endorsed as occurring during treatment, unpleas-
ant memories, stress, and anxiety were each experienced by more than one-third of the partici-
pants in the current study. Other items associated with symptoms were also common,
indicating that adverse and unwanted events linked to novel and increased symptomatology in
treatment should be reasonable to expect. This is further evidence by the fact that this factor
alone accounted for 36.58% of the variance in the EFA. In addition, five items related to the
quality of the treatment were each endorsed by at least one-quarter of the participants, suggest-
ing that this too might constitute a recurrent type of negative effect. Items related to the same
two factors also contributed with the highest self-rated negative impact, implying that perceiv-
ing the treatment or therapeutic relationship as deficient, or experiencing different types of
symptoms could be harmful for the patient. Thus, in order to prevent negative effects from
occurring, different actions might be necessary to ensure a good treatment-patient fit, i.e., the
right type of treatment for a particular patient, instilling confidence, as well as dealing with the
patient’s expectations of treatment and bond with the therapist. Additionally, monitoring and
managing symptoms by using the NEQ would also be important [23], especially given the fact
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that many therapists are unaware or have not received adequate training of negative effects in
treatment [79].
The current study indicates that negative effects of psychological treatments seem to occur
and can be assessed using the NEQ, revealing several distinct but interrelated factors. Several
limitations, however, need to be considered in reviewing the results. First, distribution of the
instrument was made to patients at post treatment assessment or to individuals remembering
their treatment retrospectively, with few participants presently being in treatment. Thus, there
is a strong risk of recall effects exerting an influence, e.g., forgetting some adverse and
unwanted events that have occurred, or only recognizing negative effects that happened early
on or very late in treatment, i.e., primacy-recency effects [48]. Administering the NEQ on
more than one occasion, e.g., mid-assessment, could perhaps prevent some of this problem and
is therefore recommended in future studies. Although, recurrently probing for negative effects
may pose a risk of inadvertently inducing adverse and unwanted events, i.e., making the patient
more aware of certain incidents, which also needs to be recognized. Moreover, it may be impor-
tant to explore whether the negative effects that are reported differ between those currently
undergoing psychological treatment and those that have recently ended it, particularly because
it could be affected by the treatment interventions they are receiving. This is also true for differ-
ent treatment modalities, as it could be argued that the participants in the treatment group
experienced negative effects that are very specific for a smartphone-delivered self-help treat-
ment for social anxiety disorder. The inclusion of the media group, which was more heteroge-
neous in nature, may have prevented some of this problem, but further research should be
conducted with more diverse samples in mind. Second, providing a list of negative effects is
regarded as an aid for the participants in order to recollect adverse and unwanted events that
might have been experienced during treatment. However, such alternatives could also poten-
tially affect the responses made by the participant, that is, choosing among negative effects that
may not otherwise have been considered [80]. Given that the items included in the NEQ were
partly developed using the results from open-ended questions, the alternatives should never-
theless still reflect adverse and unwanted events that are reasonable to assume among the par-
ticipants. Third, with regard to the sensitive issue surrounding negative effects of psychological
treatments, an instrument probing for adverse and unwanted events is probably prone to pro-
duce social desirability or induce other types of biases. Krosnick [48] provides a lengthy discus-
sion on this issue, suggesting that norms, cohesion, and personal characteristics influence a
participant’s ability to respond truthfully and validly. It could be argued that patients that are
satisfied with the outcome of their treatment choose not to respond because of gratitude toward
the researcher or therapist. Similarly, patients that are displeased with their treatment or thera-
pist may decline to answer, or, alternatively, exaggerate the responses in order to convey their
discontent. This is particularly relevant in relation to the media group, where the participants
were recruited on the grounds of having experienced negative effects, making it plausible that
only those who were unhappy about their psychological treatments responded, creating selec-
tion bias. Hence, future investigations should aim to replicate the findings in the current study
by distributing the NEQ to random samples, for instance, at different outpatient clinics. Like-
wise, despite a low dropout rate from the treatment group (9.6%), it is possible that those who
did not complete the post treatment assessment, including the NEQ, may have been those who
experienced deterioration, nonresponse, or adverse and unwanted events to a greater degree.
Thus, the findings in the current study may have missed negative effects that were perceived
but just not reported. Again, distributing the NEQ not only at post treatment assessment
should avoid some of this shortcoming, as would follow-up interviews on those who choose
not to continue with the treatment program. Fourth, administering an instrument that includes
60 items pose a risk of introducing a cognitive load on the participants, especially if used in
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adjunct to other measures. This could have affected the validity of the responses as research
indicates that participants often try to preserve mental resources when filling out different
questionnaires, compromising the quality for more arbitrarily chosen answers [80]. In relation
to the individuals in the media group this may not have been an issue, but for the patients in
the treatment group the instrument developed for the current study was one of seven outcome
measures to be completed. Thus, for future studies, the problem of cognitive load needs to be
considered. The NEQ now consists of 32 items and should avoid some of this problem, but the
administration of the instrument on a separate occasion is nonetheless recommended. Fifth,
albeit the current study has provided some evidence of negative effects of psychological treat-
ments, the association between its occurrence and implications for outcome is still unclear.
Adverse and unwanted events that arise during treatment might be a transient phenomenon
related to either the natural fluctuations in psychiatric disorders or treatment interventions
that are negatively experienced by the patient, but helpful in the long-run. Alternatively, such
negative effects may have an impact that prevents the patient from benefitting from treatment,
resulting in deterioration, hopelessness, and a sense of failure. To investigate this issue, the
NEQ therefore needs to be accompanied by other outcome measures. By collecting data from
several time points throughout treatment and relating it to more objective results, both at post
treatment assessment and follow-up, it should be possible to determine what type of impact
adverse and unwanted events actually have for the patient. Sixth, even though there exist sev-
eral methods for validating a factor solution from an EFA, the findings are still to some extent
a result of making subjective choices [53]. Relying solely on the Kaiser criterion or scree test
provide a relatively clear criterion for obtaining the factor solution, such as, using eigenvalues
greater than one as a cutoff, but risk missing factors that are theoretically relevant for the
underlying construct(s) [54]. Likewise, such methods often lead to over- or underfactoring and
is thus not regarded as the only mean for determining the number of factors to retain [57]. In
the current study, a six-factor solution seemed most reasonable, particularly as it fits well with
prior theoretical assumptions and empirical findings, which is one way of validating the results
[62]. A parallel analysis and a stability analysis also provided some support for the findings,
but such methods also have a number of limitations [53]. Most notably, factors that are ran-
domly generated still have to be compared to a factor solution that is subjectively chosen, and
the selection of a random number of cases to retest the factors are still derived from the same
sample. Thus, it should be noted that replications are needed to fully ascertain if the obtained
factor solution is truly valid and stable across samples. This would, however, warrant recruiting
patients and individuals from additional settings, and to implement alternative statistical meth-
ods, such as Rasch-analysis, which has some benefits in investigating data where the level of
measurement can be assumed to be quasi-interval [81]. Lastly, using EFA to determine theoret-
ically interesting latent constructs does not imply that the items that were not retained are
inapt, only that they did not fit the uni- or multidimensionality of the final factor solution.
Hence, some of the items that were originally generated may still be clinically relevant, and the
open-ended question included in the instrument may in the future reveal other items that are
of interest.
Conclusions
The current study tested an instrument for measuring adverse and unwanted events of psycho-
logical treatments, the NEQ, and was evaluated using EFA. The results revealed a six-factor
solution with 32 items, defined as: symptoms, quality, dependency, stigma, hopelessness, and
failure, accounting for 57.64% of the variance. Unpleasant memories, stress, and anxiety were
experienced by more than one-third of the participants, and the highest self-rated negative
The Negative Effects Questionnaire
PLOS ONE | DOI:10.1371/journal.pone.0157503 June 22, 2016 17 / 22
impact was linked to increased or novel symptoms, as well as lack of quality in the treatment
and therapeutic relationship.
Availability
The NEQ is freely available for use in research and clinical practice At time of writing, the
instrument has been translated by professional translators into the following languages, avail-
able for download via the website www.neqscale.com: Danish, Dutch, English, Finnish, French,
German, Italian, Japanese, Norwegian, Spanish, and Swedish.
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